A murine monoclonal anti-DNA antibody, PME77, with specificity for double-stranded DNA, has previously been shown to react with a protein(s) present at the surface of such cells involved in lupus pathogenesis as human glomeruli, T and B lymphocytes, erythrocytes, and platelets. Mild elastase treatment of lymphoid cells from non-autoimmune (CBA/ca or BALB/c) mice releases a series of crossreactive polypeptides (34, 33, 17, 16, and 14 Most lesions observed in murine and human systemic lupus erythematosus (SLE) are considered to be associated with the presence of anti-double-stranded DNA (dsDNA) antibodies that are spontaneously produced in large amounts. The antibodies are believed to be deposited in the form of DNA-anti-DNA immune complexes in many organs, especially the kidneys (1). It is difficult, however, to produce antibodies to dsDNA by deliberate immunization (2). To study these antibodies, we analyzed the properties of PME77, a monoclonal antibody (mAb) with anti-dsDNA specificity, prepared from spleen cells of an autoimmune (NZB x NZW)F1 B/W mouse. mAb PME77 has been shown to react with a protein(s) present at the surface of a variety of normal cell types known to play a role in lupus pathogenesis (3, 4). Furthermore, it has been shown (13) Serum. MRL-lpr/lpr, B/W, and BALB/c sera were heated for 30 min at 56°C to inactivate complement and then stored at -20°C.
Most lesions observed in murine and human systemic lupus erythematosus (SLE) are considered to be associated with the presence of anti-double-stranded DNA (dsDNA) antibodies that are spontaneously produced in large amounts. The antibodies are believed to be deposited in the form of DNA-anti-DNA immune complexes in many organs, especially the kidneys (1) . It is difficult, however, to produce antibodies to dsDNA by deliberate immunization (2) . To study these antibodies, we analyzed the properties of PME77, a monoclonal antibody (mAb) with anti-dsDNA specificity, prepared from spleen cells of an autoimmune (NZB x NZW)F1 B/W mouse. mAb PME77 has been shown to react with a protein(s) present at the surface of a variety of normal cell types known to play a role in lupus pathogenesis (3, 4) . Furthermore, it has been shown (13) that the ectodomain of this membrane bound protein(s) can be released as a series of polypeptides by mild treatment with elastase. However, this protein(s) appears to be destroyed by mild treatment of the same cells with trypsin or papain.
In this paper we show that the protein(s) present at the Serum. MRL-lpr/lpr, B/W, and BALB/c sera were heated for 30 min at 56°C to inactivate complement and then stored at -20°C.
Murine mAb. The hybridoma secreting anti-DNA antibody PME77 was obtained after fusion between a nonsecreting myeloma line (P3X63Ag8.653) and B/W spleen cells. PME77 mAb was shown to be an IgG2b, K-chain antibody specific for dsDNA (5, 6) .
Elution of Immunoglobulins from Kidneys of MRL-lpr/lpr Autoimmune Mice and BALB/c Mice. Eight MRL-lpr/lpr mice and eight BALB/c mice were perfused with 20 ml of 0.9% NaCl and their kidneys were frozen in nitrogen liquid.
Sixteen kidneys of MRL-lpr/lpr mice and 16 kidneys of BALB/c mice were pooled, cut into small pieces while still frozen, suspended in phosphate-buffered saline (PBS:0.15 M NaCl/150 mM phosphate, pH 7.2), and then homogenized in a chilled Waring Blendor at 0°C. The homogenate was washed at 4°C with 500 ml of PBS by centrifugation at 4000 x g. This washing procedure was repeated three times, and the pellet was resuspended and incubated for 2 hr at 37°C in 20 volumes of 0.02 M citrate buffer at pH 3.2 (7). After elution, the suspension was centrifuged (4000 x g for 30 min), and the eluates were neutralized (pH 7.0) with 1 M Na2HPO4, dialyzed against PBS overnight, concentrated, adjusted to 2 ml, and stored at -20°C. The optical density at 280 nm was approximately 3.7 for MRL-lpr/lpr and 1.1 for BALB/c.
ELISA. The assay for the detection of eluted IgG from kidneys was performed as described (8) . In brief, microtest plates (Luxlon, CEB, Nemours, France) were coated with goat anti-mouse IgG antiserum (Cappel Laboratories, Cochranville, PA) diluted to a concentration of 2 ,ug/ml in borate buffer (pH 8.2) containing 0.2 M NaCl. After an overnight incubation at 4°C, the plates were washed in PBS containing 1% bovine serum albumin at room temperature for 1 hr. Eluted IgG was then added. After the plates were incubated for 1 hr at 37°C and then washed three times with PBS containing 0.1% (vol/vol) Tween 20, 100 ,u of 0-galactosidase-labeled goat anti-mouse IgG antiserum (Biosis, Compiegne, France) diluted 1:500 was added and left to incubate 1 hr at 37°C. Plates were then washed three times in PBS/Tween 20 before the Abbreviations: dsDNA, double-stranded DNA; mAb, monoclonal antibody; SLE, systemic lupus erythematosus.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (9) . The lymphoblastoid B-cell line Raji was obtained as described (3) . Cell lines were maintained in suspension culture in RPMI 1640 medium supplemented with heat-inactivated fetal bovine serum (5%), penicillin (100 units/ml), and streptomycin (100 ,ug/ml), all from GIBCO.
Gel Electrophoresis and Immunoreplica Analysis of IW32 Cell Extract. The extract of IW32 cells was prepared as described (3) . NaDodSO4/polyacrylamide gel electrophoresis (10) was done in a slab gel. After electrophoresis, the immunoreplica technique was carried out as described by Burnette (11) and modified by Coudrier et al. (12) . After electrophoretic transfer of polypeptides, the nitrocellulose sheet was incubated with the supernatant of PME77 mAbsecreting hybridoma or with eluted IgG of MRL-lpr/lpr mice for 90 min at room temperature. Antigen-antibody complexes were detected by a peroxidase technique (3).
Comparison of Immunoreplica Analysis Before and After
Elastase Treatment of Living Cells. Two total cellular extracts of IW32 cells were prepared as described above. One was from cells that had been treated with elastase (100 ,ug/ml) for 1 hr at 0°C; the second extract was from cells not subjected to elastase digestion. In both cases, cell viability was at least 95%.
Elastase, Trypsin, and Papain Treatment of Cells. One hundred million viable spleen cells obtained from CBA/ca, BALB/c, MRL-lpr/lpr, or B/W mice (after red-cell lysis)
were treated in 1 ml of 0.15 M NaCl/50 mM Tris Cl, pH 8.0, for 7 min with elastase (final concentration, 10 ,ug/ml; Merck) on ice. One hundred million viable spleen cells from CBA/ca, MRL-lpr/lpr, or B/W mice were treated in 1 ml of PBS (pH 7.5) for 7 min with trypsin (final concentration, 10 ,g/ml; Boehringer Mannheim) on ice. One hundred million viable spleen cells from CBA/ca or MRL-lpr/lpr mice were treated in 1 ml of PBS/5 mM EDTA/2.5 mM cysteine, pH 7.5, for 7 min with papain (final concentration, 10 ;Lg/ml; Boehringer Mannheim) on ice.
Cell surface proteins released by these mild protease treatments were separated from the cells by low-speed centrifugation (200 x g, for 7 min). Aliquots of the "elastase supernatant," the "trypsin supernatant," and the "papain supernatant" were subjected to NaDodSO4/polyacrylamide slab gel electrophoresis followed by immunoreplica analysis.
DNA-Binding Capacity. The DNA-binding capacity of sera and hybridoma supernatants was measured by a solid-phase radioimmunoassay (5).
RESULTS
Polypeptides Released by Protease Treatment from the Surface of Cells of Non-Autoimmune or Autoimmune Mice. We first compared the polypeptides recognized by mAb PME77 after treatment of cells from non-autoimmune (CBA/ ca and BALB/c) or autoimmune (MRL-lpr/lpr and B/W) mice with proteases. Cells were treated as described in Materials and Methods with either elastase, trypsin, or papain. After centrifugation, the supernatants were subjected to NaDodSO4/polyacrylamide gel electrophoresis followed by transfer to nitrocellulose and immunodetection with mAb PME77 (Fig. 1) . As previously shown (13) , in the supernatant derived from "normal" cells, PME77 detected a series offive polypeptides of 34, 33, 17, 16, and 14 kDa. However, PME77 detected no polypeptide either in the supernatant or in the pellet of the same cells treated with trypsin or papain, a result indicating a high sensitivity of the surface protein(s) to protease digestion.
In contrast, when spleen cells from autoimmune MRLlpr/lpr and B/W mice were treated in a similar way, a major polypeptide of 55 kDa was detected by PME77 in the supernatants obtained with any of the three proteases. This result indicates that the protein(s) expressed at the surface of the cells of autoimmune mice displays different sensitivity to proteases than those observed in non-autoimmune mice.
Sera from Autoimmune Mice Recognize the Same Polypeptides as mAb PME77. If the polypeptides released by protease treatment were involved in lupus pathogenesis, one would expect to find in the sera of autoimmune, but not of normal mice, antibodies with specificity similar to that of PME77. We investigated this question by immunoreplica analysis of sera from autoimmune and normal mice. As shown in Fig. 2 Immunology: Jacob et al. solid-phase radioimmunoassay ( Table 1) . As shown in Fig. 3 (14) , it is at least reasonable to consider, as an alternative, the role of a protein rather than DNA in SLE pathogenesis.
This point is strengthened by the finding that the protein(s) expressed at the surface of cells from autoimmune B/W and MRL-lpr/lpr mice displayed altered sensitivity to proteases. This could result from a change either in the structure of the protein(s) itself or in its environment in the membrane [such as, for example, circulating autoantibodies against the lupusassociated membrane protein(s) (LAMP)]. It is clear, however, that, whatever their origin, such modifications might result in the appearance of a non-self antigen and therefore elicit an autoimmune response. We suggest that a similar situation may apply to other autoimmune diseases (for instance, to the acetylcholine receptor in myasthenia gravis).
